Login / Signup

Should we continue to use tenofovir disoproxil fumarate/lamivudine/dolutegravir for treatment of pregnant women? Interpreting the PROMISE trial.

Andrew M HillDaniel Elbirt
Published in: AIDS (London, England) (2024)
Keyphrases
  • pregnant women
  • hiv infected patients
  • antiretroviral therapy
  • clinical trial
  • phase iii
  • big data
  • machine learning